Bariatric Surgery for Sleep Apnoea: Key Facts

Bariatric surgery for sleep apnea (obstructive sleep apnoea) offers one of the most effective long-term interventions for people living with obesity-related OSA. By producing substantial, sustained weight loss, bariatric procedures directly address the excess fatty tissue that narrows the upper airway during sleep. This article explains how surgery can improve or resolve OSA, which procedures are most effective, who qualifies on the NHS, what results to expect, and the risks and side effects you should understand before making a decision.

Can bariatric surgery cure or improve sleep apnoea?

Bariatric surgery can significantly improve or resolve OSA in people with obesity by reducing the fatty tissue that narrows the upper airway, though some patients retain residual OSA due to non-weight-related factors such as craniofacial anatomy.

Bariatric surgery can significantly improve or, in many cases, resolve obstructive sleep apnoea (OSA) in people with obesity, with studies consistently showing reductions in apnoea-hypopnoea index (AHI) scores following substantial weight loss. OSA occurs when excess fatty tissue around the neck and upper airway narrows or collapses the airway during sleep, causing repeated breathing interruptions. Because bariatric surgery produces sustained, substantial weight loss, it directly addresses one of the primary anatomical drivers of the condition. OSA is, however, multifactorial: craniofacial structure, ventilatory control instability, and other non-weight-related factors can also contribute, which is why some degree of OSA may persist even after major weight loss.

The relationship between weight and OSA is well established. Even modest reductions in body weight can reduce OSA severity, but the degree of improvement seen after bariatric surgery is typically far greater than that achieved through lifestyle changes or medical management alone. OSA severity is classified by AHI: mild (5 to 14 events per hour), moderate (15 to 29 events per hour), and severe (30 or more events per hour). Resolution is generally defined as an AHI below 5 events per hour off continuous positive airway pressure (CPAP) therapy, confirmed by a repeat sleep study. Some patients achieve this; others see a meaningful reduction in severity that may allow them to reduce or discontinue CPAP, though this should always be confirmed with objective reassessment.

It is important to note that bariatric surgery is not a guaranteed cure. A proportion of patients retain some degree of OSA after surgery, particularly those with non-obesity-related anatomical factors such as craniofacial abnormalities or central sleep apnoea. Age, the duration of OSA before surgery, and the degree of weight loss achieved all influence outcomes. Patients should continue to be monitored by their sleep medicine team after surgery rather than assuming the condition has resolved without objective reassessment.

For those exploring weight management options, Bolt Pharmacy is a GPhC-registered UK online pharmacy offering online weight-management consultations, with prescriber review and pharmacist support, as part of a broader pathway that may include referral for surgical assessment where appropriate.

Which weight loss operations are most effective for sleep apnoea?

Roux-en-Y gastric bypass and sleeve gastrectomy produce the greatest OSA benefit, with gastric bypass generally delivering the most durable weight loss and corresponding improvement in AHI scores.

Roux-en-Y gastric bypass and sleeve gastrectomy are the two procedures most commonly associated with significant improvement in obstructive sleep apnoea, with gastric bypass generally producing the greatest and most durable weight loss and corresponding OSA benefit, though outcomes vary between individuals and across studies.^[4][5] Both operations are performed laparoscopically in most UK centres and are commissioned by NHS Integrated Care Boards (ICBs) in line with NICE guidance.

Gastric bypass works by creating a small stomach pouch and rerouting the small intestine, producing both restriction of food intake and changes in gut hormones that reduce appetite and improve metabolic function. Sleeve gastrectomy removes a large portion of the stomach, leaving a narrow tube that limits intake and also alters appetite-regulating hormones. Both procedures produce substantial and sustained weight loss, which is the primary mechanism through which OSA improves. It is worth noting that sleeve gastrectomy can worsen gastro-oesophageal reflux symptoms in some patients, and this is a factor the multidisciplinary team will consider when recommending a procedure.^[7][8]

Adjustable gastric banding, once widely used, is now performed far less frequently in the UK because it produces less weight loss and has higher rates of long-term complications and revisional surgery. Evidence suggests it is less effective than bypass or sleeve procedures for OSA resolution.^[4] Biliopancreatic diversion with duodenal switch produces the greatest weight loss of all bariatric procedures but is performed in fewer centres due to its complexity and nutritional risks.

The choice of procedure depends on individual clinical factors including BMI (kg/m²), comorbidities, anatomy, and patient preference, and is made jointly by the patient and a specialist multidisciplinary team. OSA severity alone does not determine which operation is recommended, but it is an important factor in the overall risk-benefit assessment, particularly given the anaesthetic implications of untreated or poorly controlled OSA.

Who qualifies for bariatric surgery on the NHS for sleep apnoea?

NHS eligibility follows NICE guidance: adults with a BMI of 35 kg/m² or above with OSA as a qualifying comorbidity, or BMI 40 kg/m² or above regardless of comorbidities, subject to local ICB criteria.

NHS eligibility for bariatric surgery is determined by NICE guidance on the assessment and management of overweight and obesity, which recommends surgery for adults with a BMI of 35 kg/m² or above who have one or more obesity-related comorbidities, including obstructive sleep apnoea, or for adults with a BMI of 40 kg/m² or above regardless of comorbidities. OSA is explicitly recognised as a qualifying comorbidity, and its presence can support a referral even at the lower BMI threshold. Patients should check the current NICE guidance and their local ICB criteria, as thresholds and commissioning arrangements are subject to update.

NICE guidance also recognises that lower BMI thresholds may be appropriate for people from South Asian, Chinese, and some other minority ethnic backgrounds, in whom the health risks associated with excess weight occur at lower BMI values.^[9][10] Clinicians should apply ethnicity-adjusted thresholds where relevant.

To be considered, patients generally need to have tried and engaged with non-surgical weight management interventions, though NICE guidance acknowledges that surgery may be considered as a first-line option in certain clinical circumstances, particularly where comorbidities are severe or rapidly worsening. Referral is made by a GP to a specialist bariatric service, and the decision about whether to proceed is made by a multidisciplinary team including a bariatric surgeon, dietitian, psychologist, and physician.

Local commissioning decisions are made by ICBs, and access can vary across England. Scotland, Wales, and Northern Ireland have their own commissioning arrangements. Some ICBs apply additional criteria beyond the NICE thresholds, such as requirements for documented engagement with a tier 3 weight management service before surgical referral. Patients should ask their GP about local pathways, as waiting times and criteria differ.

Sleep apnoea should be formally diagnosed before referral, ideally with a sleep study confirming OSA severity. Patients using CPAP therapy should continue to do so in the period leading up to surgery, and should bring their CPAP equipment to hospital for use perioperatively, as untreated OSA significantly increases anaesthetic and perioperative risk. The bariatric team will liaise with the sleep medicine service as part of preoperative assessment.

What results can you realistically expect after surgery?

Most patients experience a clinically meaningful reduction in OSA severity, with a substantial proportion achieving full resolution, though objective confirmation via a repeat sleep study at around 12 months is required.

Most patients who undergo bariatric surgery for obesity-related obstructive sleep apnoea experience a clinically meaningful reduction in OSA severity, with a substantial proportion achieving complete resolution (defined as AHI below 5 events per hour off CPAP), particularly those who achieve significant and sustained weight loss in the first one to two years after surgery. Published evidence, including systematic reviews and meta-analyses, suggests that gastric bypass is associated with OSA resolution in a large proportion of patients, though figures vary across studies depending on how resolution is defined, baseline OSA severity, and the duration of follow-up.^[1][2]

Improvement in OSA typically begins within weeks of surgery as weight starts to reduce, and many patients report better sleep quality, reduced daytime sleepiness, and improved energy levels relatively early in their recovery. However, objective confirmation of OSA resolution requires a repeat sleep study, usually recommended around 12 months after surgery or once weight loss has stabilised, in line with typical sleep service practice. Patients should not discontinue CPAP therapy without clinical guidance, even if they feel subjectively better.

Patients with moderate or severe OSA and excessive daytime sleepiness have legal obligations regarding driving. The DVLA publishes guidance on fitness to drive with sleep apnoea, and patients should follow this guidance and notify the DVLA where required.^[12][13] After surgical treatment and objective reassessment, patients should recheck their driving status with their sleep medicine team and the DVLA as appropriate.

Weight regain over time can lead to partial or full recurrence of OSA in some patients. Long-term outcomes are best in those who maintain lifestyle changes, attend follow-up appointments, and receive ongoing support from a multidisciplinary team. Bariatric surgery is not a passive intervention and requires sustained commitment to dietary and behavioural change.

Other obesity-related conditions, including type 2 diabetes, hypertension, and gastro-oesophageal reflux disease, often improve alongside OSA after surgery, which can have a compounding benefit on cardiovascular risk and overall quality of life. Patients should discuss realistic expectations with their surgical team before proceeding, including the possibility that some degree of OSA may persist even after successful weight loss.

Risks, side effects, and when to seek help after bariatric surgery

Bariatric surgery carries short-term risks including anastomotic leak and venous thromboembolism, and long-term risks including nutritional deficiencies requiring lifelong supplementation and monitoring per BOMSS guidance.

Bariatric surgery carries both short-term operative risks and longer-term nutritional and surgical complications that patients must understand before consenting to a procedure. Short-term risks include bleeding, infection, anastomotic leak, venous thromboembolism, and adverse reactions to anaesthesia, which is itself more complex in patients with active OSA. Perioperative mortality is low in specialist centres but is not zero, and risk increases with higher BMI, older age, and poorly controlled comorbidities.

Longer-term side effects vary by procedure but commonly include:

• Nutritional deficiencies, particularly of iron, vitamin B12, folate, calcium, and vitamin D, requiring lifelong supplementation and regular blood monitoring in line with British Obesity and Metabolic Surgery Society (BOMSS) guidance

• Dumping syndrome after gastric bypass, causing nausea, flushing, and diarrhoea following sugary or high-fat foods

• Reflux symptoms, which may worsen after sleeve gastrectomy in some patients

• Hair thinning in the first six to twelve months, usually temporary

• Psychological adjustment difficulties, including changes in relationship with food and, rarely, transfer addiction

• Internal hernia and marginal ulcers, which are recognised long-term risks specific to Roux-en-Y gastric bypass; patients should avoid non-steroidal anti-inflammatory drugs (NSAIDs) where possible, stop smoking, and follow their surgical team's advice on proton pump inhibitor use in the early postoperative period

Patients of childbearing potential should be advised to avoid pregnancy for at least 12 to 18 months after bariatric surgery, as rapid weight loss and nutritional deficiencies during this period carry risks for both mother and baby.^[14][15] Reliable contraception should be discussed before surgery, as the absorption of oral contraceptives may be affected after some procedures.^[17][18] Patients who are breastfeeding or planning to breastfeed should seek specialist advice regarding supplementation.

Patients should seek urgent help by calling 999 or attending A&E if they experience:

• Severe abdominal pain or shoulder tip pain

• Persistent vomiting

• Signs of internal bleeding such as dark stools or dizziness

• Fever, sustained rapid heart rate, or other signs of infection or anastomotic leak

• Unilateral calf swelling or pain, sudden chest pain, or breathlessness, which may indicate deep vein thrombosis or pulmonary embolism

• Difficulty breathing in the early postoperative period

For non-emergency concerns, NHS 111 can provide advice, and routine follow-up queries should go through the bariatric team or GP. Patients should attend all scheduled follow-up appointments, as nutritional monitoring and ongoing support are essential components of safe long-term care after bariatric surgery.

Suspected side effects from any medicines used as part of the perioperative or weight management pathway can be reported to the MHRA via the Yellow Card scheme at yellowcard.mhra.gov.uk.

Scientific References

1. Bariatric Surgery or Non-Surgical Weight Loss for Obstructive Sleep Apnoea? A Systematic Review and Comparison of Meta-analyses.
2. Weight reduction and the impact on apnea-hypopnea index: A systematic meta-analysis.
3. Effects of sleeve gastrectomy on populations with obesity and obstructive sleep apnea: a meta-analysis.
4. Improvement of Obesity-Related Comorbidities After Bariatric Procedures: A Network Meta-Analysis of Endoscopic Versus Surgical Interventions.
5. Ten-Year Follow-Up for Sleeve Gastrectomy Versus Roux-en-Y Gastric Bypass: A Systematic Review and Meta-Analysis.
6. Long-Term Outcomes in Sleeve Gastrectomy versus Roux-en-Y Gastric Bypass: A Systematic Review and Meta-Analysis of Randomised Trials.
7. Laparoscopic Sleeve Gastrectomy Versus One-Anastomosis Gastric Bypass and the Risk of De Novo or Persistent Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis.
8. Conversion to One-Anastomosis Gastric Bypass versus Roux-en-Y Gastric Bypass for Treatment of Gastroesophageal Reflux Disease after Sleeve Gastrectomy: A Systematic Review and Meta-analysis.
9. Overweight and obesity management (NG246): Medicines and surgery.
10. NG246 Appendix A1: Summary of evidence from surveillance.
11. Systematic Review and Meta-Analysis of Randomised Controlled Trials Comparing Roux-en-Y Gastric Bypass with Sleeve Gastrectomy.
12. Excessive sleepiness and driving.
13. Miscellaneous conditions: assessing fitness to drive.
14. Does Bariatric Surgery Affect Pregnancy in Women in the Childbearing Period? A Retrospective Single Centre Study.
15. Pregnancy after bariatric surgery and adverse perinatal outcomes: A systematic review and meta-analysis.
16. Bariatric surgery and birth defects: A systematic literature review.
17. Oral Contraceptives after Bariatric Surgery.
18. Bioavailability of Orally Administered Drugs After Bariatric Surgery.
19. Pharmacokinetics of oral levonorgestrel and ethinylestradiol in women after Roux-en-Y gastric bypass surgery.
20. Prophylactic PPI help reduce marginal ulcers after gastric bypass surgery.
21. Perioperative Interventions to Prevent Gastroesophageal Reflux Disease and Marginal Ulcers After Bariatric Surgery – an International Experts' Survey.
22. Benefits of Prophylactic Proton Pump Inhibitors after Roux-en-Y Gastric Bypass Surgery: A Retrospective Study.

Frequently Asked Questions